Get started
Longeveron Inc.Longeveron Inc.Longeveron Inc.

Longeveron Inc.

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Forecast Seasonals

LGVN chart


Full chart

Key facts today


On April 22, 2025, Longeveron Inc. updated shareholders on its strategy, highlighting progress in stem cell therapy research, especially with laromestrocel (Lomecel-B™) for HLHS and Alzheimer's.
Analyze the impactAnalyze the impact

LGVN upcoming earnings


Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪22.74 M‬ USD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−4.05 USD
Net income (FY)
‪−15.97 M‬ USD
Revenue (FY)
‪2.39 M‬ USD
Shares float
‪12.38 M‬
Beta (1Y)
2.63

Employees


Employees (FY)
26
Change (1Y)
+1 +4.00%
Revenue / Employee (1Y)
‪92.00 K‬ USD
Net income / Employee (1Y)
‪−614.35 K‬ USD

About Longeveron Inc.


Sector
Health Technology
Industry
Biotechnology
CEO
Mohamed Wa’el Ahmed Hashad
Website
longeveron.com
Headquarters
Miami
Founded
2014
FIGI
BBG00YZ6JHT4
Longeveron, Inc. is a clinical stage biotechnology company, which engages in the development of cellular therapies for specific aging-related and life-threatening conditions. Its lead product, LOMECEL-B, is a cell-based therapy product, which is derived from culture-expanded medicinal signaling cells that are sourced from bone marrow of young, healthy, adult donors. The company was founded by Joshua M. Hare and Donald M. Soffer on October 9, 2014 and is headquartered in Miami, FL.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

LGVN news



Ideas



See all ideas 

Technicals


Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Check out other big names from the same industry as LGVN.

Frequently Asked Questions


The current price of LGVN is 1.61 USD — it has increased by 2.63% in the past 24 hours. Watch Longeveron Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Longeveron Inc. stocks are traded under the ticker LGVN.
LGVN stock has risen by 8.33% compared to the previous week, the month change is a −11.86% fall, over the last year Longeveron Inc. has showed a −15.71% decrease.
We've gathered analysts' opinions on Longeveron Inc. future price: according to them, LGVN price has a max estimate of 10.00 USD and a min estimate of 6.00 USD. Watch LGVN chart and read a more detailed Longeveron Inc. stock forecast: see what analysts think of Longeveron Inc. and suggest that you do with its stocks.
LGVN reached its all-time high on Nov 24, 2021 with the price of 450.00 USD, and its all-time low was 0.77 USD and was reached on Jun 11, 2024. View more price dynamics on LGVN chart.
See other stocks reaching their highest and lowest prices.
LGVN stock is 4.55% volatile and has beta coefficient of 2.63. Track Longeveron Inc. stock price on the chart and check out the list of the most volatile stocks — is Longeveron Inc. there?
Today Longeveron Inc. has the market capitalization of ‪23.33 M‬, it has decreased by −2.01% over the last week.
Yes, you can track Longeveron Inc. financials in yearly and quarterly reports right on TradingView.
Longeveron Inc. is going to release the next earnings report on May 9, 2025. Keep track of upcoming events with our Earnings Calendar.
LGVN earnings for the last quarter are −0.43 USD per share, whereas the estimation was −0.37 USD resulting in a −17.26% surprise. The estimated earnings for the next quarter are −0.33 USD per share. See more details about Longeveron Inc. earnings.
Longeveron Inc. revenue for the last quarter amounts to ‪603.00 K‬ USD, despite the estimated figure of ‪578.66 K‬ USD. In the next quarter, revenue is expected to reach ‪600.33 K‬ USD.
LGVN net income for the last quarter is ‪−4.08 M‬ USD, while the quarter before that showed ‪−4.42 M‬ USD of net income which accounts for 7.65% change. Track more Longeveron Inc. financial stats to get the full picture.
No, LGVN doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Apr 23, 2025, the company has 26 employees. See our rating of the largest employees — is Longeveron Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Longeveron Inc. EBITDA is ‪−15.56 M‬ USD, and current EBITDA margin is −650.63%. See more stats in Longeveron Inc. financial statements.
Like other stocks, LGVN shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Longeveron Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Longeveron Inc. technincal analysis shows the buy rating today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Longeveron Inc. stock shows the sell signal. See more of Longeveron Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.